Vapiwala, N., Chen, Y.-H., Cho, S. Y., Duan, F., Kyriakopoulos, C., Morgans, A. K., … Carducci, M. A. (2023). Phase III study of local or systemic therapy intensification directed by PET in prostate cancer patients with post-prostatectomy biochemical recurrence (INDICATE): ECOG-ACRIN EA8191. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41).

Vapiwala, Neha, Yu-Hui Chen, Steve Y. Cho, Fenghai Duan, Christos Kyriakopoulos, Alicia K. Morgans, Daniel H. Shevrin, et al. “Phase III study of local or systemic therapy intensification directed by PET in prostate cancer patients with post-prostatectomy biochemical recurrence (INDICATE): ECOG-ACRIN EA8191.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 41, 2023.

Vapiwala N, Chen Y-H, Cho SY, Duan F, Kyriakopoulos C, Morgans AK, et al. Phase III study of local or systemic therapy intensification directed by PET in prostate cancer patients with post-prostatectomy biochemical recurrence (INDICATE): ECOG-ACRIN EA8191. In: JOURNAL OF CLINICAL ONCOLOGY. 2023.

Vapiwala, Neha, et al. “Phase III study of local or systemic therapy intensification directed by PET in prostate cancer patients with post-prostatectomy biochemical recurrence (INDICATE): ECOG-ACRIN EA8191.” JOURNAL OF CLINICAL ONCOLOGY, vol. 41, no. 16, 2023.

Vapiwala N, Chen Y-H, Cho SY, Duan F, Kyriakopoulos C, Morgans AK, Shevrin DH, Koontz BF, McKay RR, Yu EY, McConathy J, Liu G, Mankoff DA, Wong TZ, Carducci MA. Phase III study of local or systemic therapy intensification directed by PET in prostate cancer patients with post-prostatectomy biochemical recurrence (INDICATE): ECOG-ACRIN EA8191. JOURNAL OF CLINICAL ONCOLOGY. 2023.